Clinical Pathways Search Results

This pathway is used to evaluate the treatment of the child with suspected acquired aplastic anemia.

The NICU suspected sepsis pathway standardizes the approach to the evaluation of late onset sepsis and improves recognition of and response to severe sepsis in the NICU.

This pathway provides guidance to aid providers in determining if a blood culture is indicated in a PICU/PCU patient with a fever (temperature > 38.5°C).

The clinical pathway for child with fever guides early identification, evaluation and management of patients with high-risk factors or severe signs/symptoms of disease.

Treatment of patients with active COVID-19 disease with guidance on severity of illness, recommendations for antivirals, steroids, immunomodulators, and convalescent plasma administration.

The PICU neonatal hyperammonemia pathway guides the care for infants < 30 days of age referred or presenting to CHOP for acute care for any abnormal or elevated ammonia level.

The Beckwith-Wiedemann Syndrome (BWS) Clinical Pathway provides guidance of care for neonates/infants born at the CHOP SDU or referred from outside institutions for further evaluation and treatment with overgrowth features such as macroglossia, hyperinsulinism, omphalocele and/or a constellation of findings suspicious for BWS.

This pathway provides a detailed overview of preoperative, intraoperative, and postoperative care for the infant diagnosed with CDH during their initial hospitalization.  

The CICU pathway for ventilator weaning provides guidance on the management and weaning of conventional mechanical ventilation and extubation readiness in children in the Cardiac Intensive Care Unit.

The ventricular shunt obstruction/infection pathway details the specific care necessary in the evaluation and treatment of a child with a suspected ventricular shunt obstruction or infection.